At Braverman Reproductive Immunology, we have been diagnosing and treating Vitamin D deficiency for years that appears to be prevalent in our patients with Recurrent Pregnancy Loss. Deficiency of Vitamin D also appears to play a significant role in the propagation of autoimmune and inflammatory disorders also seen commonly on our patient population.
In this blog, we will give you a clear insight of what is known about miscarriage risk, autoimmunity (including endometriosis) and obstetrical complication in relation to Vitamin D.
Vitamin D is a fat-soluble vitamin belonging to the steroid hormone family.
Two main forms are essentials:
a significant decrease in total lipoprotein and low-density lipoprotein
At Braverman Reproductive Immunology, we are constantly studying the latest discoveries in the field of reproductive immunology and promoting their use to offer you better diagnostic, monitoring and treatments. There is a high prevalence of vitamin D deficiency in our patient population suffering from reccurent pregnancy loss and this has to be corrected prior to conception. We are systematically determining your Vitamin D levels and if appropriate, we recommend supplementation to replenish your vitamin D reserve and optimize your chances of having a healthy pregnancy.
References
1- Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. Review.
2- Agic A, Xu H, Altgassen C, Noack F, Wolfler MM, Diedrich K, Friedrich M, Taylor RN & Hornung D. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1a-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reproductive Sciences 2007 14 486–497.
3- Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L & Seto-Young D. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Hormone and Metabolic Research 2010 42 754–757.
4- Vigano` P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E, Panina-Bordignon P, Besozzi M & Di Blasio AM. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. Journal of Molecular Endocrinology 2006 36 415–424.
5- Gunville CF, Mourani PM, Ginde AA. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets. 2013 Aug;12(4):239-45. Review.
6- Taheri M, Baheiraei A, Foroushani AR, Nikmanesh B, Modarres M. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res. 2015 Jun;141(6):799-806
7- Sablok A, Batra A, Thariani K, Batra A, Bharti R, Aggarwal AR, Kabi BC, Chellani H. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin Endocrinol (Oxf). 2015 Oct;83(4):536-41.
8- Rodda CP, Benson JE, Vincent AJ, Whitehead CL, Polykov A, Vollenhoven B. Maternal vitamin D supplementation during pregnancy prevents vitamin D deficiency in the newborn: an open-label randomized controlled trial. Clin Endocrinol (Oxf). 2015 Sep;83(3):363-8.
9- Halhali A, Acker GM, Garabédian M. 1,25-Dihydroxyvitamin D3 induces in vivo the decidualization of rat endometrial cells. J Reprod Fertil. 1991 Jan;91(1):59-64.
10- Zerwekh JE, Breslau NA. Human placental production of 1 alpha,25 dihydroxyvitamin D3: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol Metab. 1986 Jan;62(1):192-6.
11- Du H, Daftary GS, Lalwani SI, Taylor HS. Direct regulation of HOXA10 by
1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol. 2005 Sep;19(9):2222-33.
12- Deng KX, Liu XC, Zheng YH, et al. Expression and significance of HOXA10 gene in the eutopic and ectopic endometrium of endometriosis. Zhonghua Fu Chan Kke Za Zhi 2011; 46:813–6.
13- Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta. 2010;31(12):1027-1034.
14- Nguyen TP, Yong HE, Chollangi T, Borg AJ, Brennecke SP, Murthi P. Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction. J Mol Med (Berl). 2015;93(7):795-805.
15- Chan SY, Susarla R, Canovas D, et al. Vitamin D promotes human extravillous trophoblast invasion in vitro. Placenta. 2015;36(4):403-409.
16- Ota K, Dambaeva S, Han AR, Beaman K, Gilman-Sachs A, Kwak-Kim J. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum Reprod. 2014 Feb;29(2):208-19.
17- Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013 Mar 1;177(5):420-30.
18- Ji JL, Muyayalo KP, Zhang YH, Hu XH, Liao AH. Immunological function of vitamin D during human pregnancy. Am J Reprod Immunol. 2017 Aug;78(2).
19- Farhangi MA,Mesgari-Abbasi M, Hajiluian G, Nameni G, Shahabi P. Adipose tissue inflammation and oxidative stress: the ameliorative effects of vitamin D. Inflammation. 2017;40(5):1688-1697.
20- Pourghassem Gargari B, Pourteymour Fard Tabrizi F, Sadien B, Asghari Jafarabadi M, Farzadi L. Vitamin D Status Is Related to Oxidative Stress But Not High-Sensitive C-Reactive Protein in Women with Pre-Eclampsia. Gynecol Obstet Invest. 2016;81(4):308-14.
21- Adorini L, Amuchastegui S, Daniel KC. Prevention of chronic allograft rejection by Vitamin D receptor agonists. Immunol Lett. 2005 Aug 15;100(1):34-41. Review.
22- Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol. 1998 Oct;28(10):3017-30.
23- Helming L, Böse J, Ehrchen J, Schiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood. 2005 Dec 15;106(13):4351-8.
24- Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol. 2004 Aug 15;173(4):2280-7.
25- Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr. 2013 Sep;143(9):1432-8.
26- Zabul P, Wozniak M, Slominski AT, Preis K, Gorska M, Korozan M, Wieruszewski J, Zmijewski MA, Zabul E, Tuckey R, Kuban-Jankowska A, Mickiewicz W, Knap N. A Proposed Molecular Mechanism of High-Dose Vitamin D3 Supplementation in Prevention and Treatment of Preeclampsia. Int J Mol Sci. 2015 Jun 9;16(6):13043-64.
27- Xu J, Jia X, Gu Y, Lewis DF, Gu X, Wang Y. Vitamin D Reduces Oxidative
Stress-Induced Procaspase-3/ROCK1 Activation and MP Release by Placental
Trophoblasts. J Clin Endocrinol Metab. 2017 Jun 1;102(6):2100-2110.
28- Arnold DL, Enquobahrie DA, Qiu C, Huang J, Grote N, VanderStoep A, Williams MA. Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2015 May;29(3):200-10.
29- Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr. 2013 Sep;143(9):1432-8.
30- Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr. 2013 Dec;98(6):1425-32.